BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
The RealReal
REAL
$1.44B
| $47.4M | ﹤0.01% |
3,704,986
+379,170
| +11% | +$4.51M |
|
2277
Arcutis Biotherapeutics
ARQT
$3.3B
| $47.4M | ﹤0.01% |
1,566,574
+701,265
| +81% | +$20.3M |
|
2278
Marcus Corp
MCS
$884M
| $47.4M | ﹤0.01% |
3,569,402
-62,592
| -2% | -$839K |
|
2279
Cue Biopharma
CUE
$119M
| $47.3M | ﹤0.01% |
64,392
+20,078
| +45% | +$14.5M |
|
|
WSR
2280
DELISTED
Whitestone REIT
WSR
| $47.3M | ﹤0.01% |
6,500,046
+98,631
| +2% | +$627K |
|
2281
Acco Brands
ACCO
$396M
| $47.1M | ﹤0.01% |
6,633,016
-261,697
| -4% | -$1.63M |
|
2282
Chewy
CHWY
$9.2B
| $47M | ﹤0.01% |
1,052,093
+71,896
| +7% | +$3.14M |
|
2283
Future Fuel
FF
$279M
| $47M | ﹤0.01% |
3,931,563
-43,243
| -1% | -$510K |
|
2284
Ingles Markets
IMKTA
$1.65B
| $47M | ﹤0.01% |
1,090,138
+37,754
| +4% | +$1.53M |
|
2285
GSK
GSK
$102B
| $46.9M | ﹤0.01% |
919,834
-199,158
| -18% | -$10.2M |
|
2286
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $46.9M | ﹤0.01% |
1,751,018
-643
| -0% | -$16.2K |
|
|
HUYA
2287
Huya Inc
HUYA
$556M
| $46.7M | ﹤0.01% |
2,503,761
-165,465
| -6% | -$2.76M |
|
2288
AnaptysBio
ANAB
$1.71B
| $46.6M | ﹤0.01% |
2,088,064
+57,394
| +3% | +$1.05M |
|
|
TBRG
2289
DELISTED
TruBridge
TBRG
| $46.6M | ﹤0.01% |
2,046,367
+18,461
| +0.9% | +$412K |
|
2290
Oil States International
OIS
$532M
| $46.6M | ﹤0.01% |
9,812,775
+276,050
| +3% | +$1.06M |
|
|
TRTX
2291
TPG RE Finance Trust
TRTX
$614M
| $46.6M | ﹤0.01% |
5,413,229
+488,509
| +10% | +$3.55M |
|
2292
1st Source
SRCE
$2.12B
| $46.5M | ﹤0.01% |
1,305,959
+140,182
| +12% | +$4.64M |
|
|
CLDT
2293
Chatham Lodging
CLDT
$580M
| $46.5M | ﹤0.01% |
7,590,573
-700,956
| -8% | -$4.7M |
|
2294
Kearny Financial
KRNY
$600M
| $46.4M | ﹤0.01% |
5,674,998
-180,276
| -3% | -$1.51M |
|
2295
Vericel Corp
VCEL
$2.27B
| $46.2M | ﹤0.01% |
3,342,827
-31,770
| -0.9% | -$430K |
|
2296
Pacific Biosciences
PACB
$354M
| $46M | ﹤0.01% |
13,343,578
+508,752
| +4% | +$1.73M |
|
2297
Haverty Furniture Companies
HVT
$443M
| $46M | ﹤0.01% |
2,873,013
-1,611
| -0.1% | -$23.5K |
|
2298
CALL
Global Payments
GPN
$22.7B
| $45.9M | ﹤0.01% |
+270,900
| New | +$45.1M |
|
2299
Krystal Biotech
KRYS
$9.68B
| $45.9M | ﹤0.01% |
1,108,984
+282,219
| +34% | +$13.6M |
|
|
CBPO
2300
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $45.7M | ﹤0.01% |
447,596
+62,703
| +16% | +$6.71M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.